Unfortunately, I have not had the benefit of listening to the various panel discussions and what I am sure were thought-provoking comments made by the various speakers over the last two days.
Therefore, to avoid the risk of repeating what others may have said, I thought I would take a broad approach to the subject and offer some thoughts on the lessons that emerging market and developing economies can draw from the financial market regulatory reform process that has taken place over the past 5 years and how this can be applied to the OTC derivative reform process.